GlobeStar Therapeutics Corporation – OTC:GSTC

GlobeStar Therapeutics stock price today

$0
-0.00
-66.67%
Financial Health
0
1
2
3
4
5
6
7
8
9

GlobeStar Therapeutics stock price monthly change

-100.00%
month

GlobeStar Therapeutics stock price quarterly change

-100.00%
quarter

GlobeStar Therapeutics stock price yearly change

-100.00%
year

GlobeStar Therapeutics key metrics

Market Cap
6.31M
Enterprise value
5.02M
P/E
-5.88
EV/Sales
N/A
EV/EBITDA
-4.22
Price/Sales
N/A
Price/Book
-4060.19
PEG ratio
-0.05
EPS
N/A
Revenue
N/A
EBITDA
-1.86M
Income
-1.97M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

GlobeStar Therapeutics stock price history

GlobeStar Therapeutics stock forecast

GlobeStar Therapeutics financial statements

GlobeStar Therapeutics Corporation (OTC:GSTC): Profit margin
Mar 2023 0 -166.59K
Jun 2023 0 -1.28M
Sep 2023 0 -350.57K
Mar 2024 0 -174.96K
0%
Yield TTM
GlobeStar Therapeutics Corporation (OTC:GSTC): Payout ratio
Payout ratio 0%
GlobeStar Therapeutics Corporation (OTC:GSTC): Dividend Yield
2019 258.83%
2020
2021
2022
2023
GlobeStar Therapeutics Corporation (OTC:GSTC): Debt to assets
Mar 2023 176 1.29M 733435.23%
Jun 2023 0 1.27M Infinity%
Sep 2023 0 1.43M Infinity%
Mar 2024 147708 1.61M 1094.29%
GlobeStar Therapeutics Corporation (OTC:GSTC): Cash Flow
Mar 2023 -53.74K 0 46.2K
Jun 2023 -40.17K 0 40K
Sep 2023 -72.69K 0 72.69K
Mar 2024 -12.38K 0 12.38K

GlobeStar Therapeutics other data

  • What's the price of GlobeStar Therapeutics stock today?

    One share of GlobeStar Therapeutics stock can currently be purchased for approximately $0.

  • When is GlobeStar Therapeutics's next earnings date?

    Unfortunately, GlobeStar Therapeutics's (GSTC) next earnings date is currently unknown.

  • Does GlobeStar Therapeutics pay dividends?

    No, GlobeStar Therapeutics does not pay dividends.

  • How much money does GlobeStar Therapeutics make?

    GlobeStar Therapeutics has a market capitalization of 6.31M.

  • What is GlobeStar Therapeutics's stock symbol?

    GlobeStar Therapeutics Corporation is traded on the OTC under the ticker symbol "GSTC".

  • What is GlobeStar Therapeutics's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of GlobeStar Therapeutics?

    Shares of GlobeStar Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • When GlobeStar Therapeutics went public?

    GlobeStar Therapeutics Corporation is publicly traded company for more then 6 years since IPO on 30 Nov 2018.

  • What is GlobeStar Therapeutics's official website?

    The official website for GlobeStar Therapeutics is globestarthera.com.

  • Where are GlobeStar Therapeutics's headquarters?

    GlobeStar Therapeutics is headquartered at 719 Jadewin Avenue, Richland, WA.

  • How can i contact GlobeStar Therapeutics?

    GlobeStar Therapeutics's mailing address is 719 Jadewin Avenue, Richland, WA and company can be reached via phone at +20 64 511970.

GlobeStar Therapeutics company profile:

GlobeStar Therapeutics Corporation

globestarthera.com
Exchange:

OTC

Full time employees:

0

Industry:

Biotechnology

Sector:

Healthcare

GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. The company was incorporated in 2016 and is headquartered in Richland, Washington.

719 Jadewin Avenue
Richland, WA 99352

CIK: 0001502152
:
: